证券代码：300165 证券简称：ST天瑞 公告编号：2025-053 江苏天瑞仪器股份有限公司 关于终止筹划公司控制权变更事项暨复牌的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、江苏天瑞仪器股份有限公司股票（股票简称：ST 天瑞，股票代码：300165） 自 2025 年 12 月 8 日（星期一）上午开市起复牌。 二、本次筹划控制权变更事项终止原因 由于公司控股股东、实际控制人与交易对方未就控制权变更相关重大事项达 成一致意见。经相关方协商一致，本着审慎的原则，决定终止本次控制权变更事 项。 2、终止筹划控制权变更事项不会对公司生产经营造成不利影响，也不会影 响公司未来的发展战略。敬请广大投资者理性投资，注意投资风险。 一、停牌事项 江苏天瑞仪器股份有限公司（以下简称"公司"）因公司控股股东、实际控 制人刘召贵先生筹划公司控制权变更相关事项，该事项可能导致公司控股股东及 实际控制人发生变更。鉴于上述事项处于筹划阶段，尚存在重大不确定性，为保 证公平信息披露，避免造成公司股价异常波动，维护广大投资者利益，根据《深 圳证券交易所上市公 ...

人民财讯12月2日电，ST天瑞（300165）12月2日公告，公司实控人刘召贵正在筹划公司控制权变更相 关事宜，该事项可能导致公司实控人发生变更。截至目前，相关各方正在积极推进此次交易的各项工 作，整体方案仍在协商，交易各方尚未签署正式协议，公司预计无法在12月3日复牌。公司股票自12月3 日开市起继续停牌，预计停牌不超过3个交易日。 ...

格隆汇12月2日丨ST天瑞(300165.SZ)公布，截至本公告披露日，相关各方正在积极推进本次交易的各项 工作，整体方案仍在协商，交易各方尚未签署正式协议，公司预计无法在2025年12月3日开市起复牌。 鉴于上述事项尚存在重大不确定性，为保证公平信息披露，避免造成公司股价异常波动，维护广大投资 者利益，根据《深圳证券交易所上市公司自律监管指引第6号——停复牌》相关规定，经公司向深圳证 券交易所申请，公司股票（股票简称：ST天瑞，股票代码：300165）自2025年12月3日（星期三）开市 起继续停牌，预计停牌时间不超过3个交易日。 登录新浪财经APP 搜索【信披】查看更多考评等级 ...

证券代码：300165 证券简称：ST天瑞 公告编号：2025-052 江苏天瑞仪器股份有限公司 关于筹划公司控制权变更事项进展暨继续停牌的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 鉴于上述事项尚存在重大不确定性，为保证公平信息披露，避免造成公司股 价异常波动，维护广大投资者利益，根据《深圳证券交易所上市公司自律监管指 引第 6 号——停复牌》相关规定，经公司向深圳证券交易所申请，公司股票（股 票简称：ST 天瑞，股票代码：300165）自 2025 年 12 月 3 日（星期三）开市起 继续停牌，预计停牌时间不超过 3 个交易日。 停牌期间，公司将根据上述事项进展情况，按照有关法律法规的规定和要求 履行信息披露义务，公司所有信息均以在中国证监会指定信息披露网站巨潮资讯 网（www.cninfo.com.cn）披露的信息为准。待上述事项确定后，公司将及时发布 相关公告并申请复牌，敬请广大投资者关注后续公告并注意投资风险。 特此公告。 江苏天瑞仪器股份有限公司董事会 二○二五年十二月二日 一、停牌情况概述 江苏天瑞仪器股份有限公司（以下简称"公司"） ...

Group 1 - Enjie Co., Ltd. is planning to acquire 100% equity of Zhongke Hualian and will suspend trading from December 1, 2025 [3] - ST Tianrui's controlling shareholder is planning a change in company control, leading to a trading suspension from December 1, 2025, expected to last no more than two trading days [4] - Jiarong Technology intends to raise no more than 1 billion yuan through a private placement and acquire 100% of Hangzhou Lanran [5] Group 2 - Baillie Gifford's subsidiary received a milestone payment of $250 million related to a collaboration agreement with Bristol-Myers Squibb [6] - Jiangxi Copper is planning to acquire shares of the overseas listed company SolGold Plc, with a non-binding cash offer of 26 pence per share [7][8] - China Shenhua's subsidiary successfully completed a 168-hour trial run of the No. 3 unit of the Beihai Phase II project, which is a key energy development project in Guangxi [9] Group 3 - Huayang Co., Ltd. has launched a high-performance carbon fiber project with an annual production capacity of 200 tons [11] - Dameng Data announced the release of its general manager from detention by the local supervisory committee [12] Group 4 - Zhongwei Company plans to reduce its stake by up to 1% through a block trade [13] - Yulide's board members plan to reduce their holdings by no more than 0.0313% of the company's total shares [14] - Saint Noble Bio's executives plan to reduce their holdings by no more than 0.024% of the company's total shares [15] Group 5 - Aoride plans to sign a comprehensive technical service agreement with a total amount of approximately 635 million yuan [16]

证券代码：300165 证券简称：ST天瑞 公告编号：2025-050 江苏天瑞仪器股份有限公司 二、采取的措施及进展情况 1、针对《行政处罚决定书》所涉事项，公司于2024年4月24日召开了第六 届董事会第七次会议和第六届监事会第五次会议，审议通过了《关于前期会计 差错更正及追溯调整的议案》，对2021年年报进行了会计差错更正及追溯调整， 并于2024年4月26日披露了《关于公司前期会计差错更正及追溯调整的公告》 （公告编号：2024-015）等相关文件。目前，公司不存在尚未整改完毕的事项。 2、根据《深圳证券交易所创业板股票上市规则》9.11条，"公司同时符合 下列条件的，可以向本所申请对其股票交易撤销其他风险警示：（一）公司已 就行政处罚决定所涉事项对相应年度财务会计报告进行追溯重述；（二）自中 国证监会作出行政处罚决定书之日起已满十二个月。"公司将在满足上述条件后 及时提出申请，争取尽早撤销风险警示。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、江苏天瑞仪器股份有限公司（以下简称"公司"）收到中国证监会出具的 《行政处罚事先告知书》 ...

证券代码：300165 证券简称：ST天瑞 公告编号：2025－051 江苏天瑞仪器股份有限公司 关于全资子公司法定代表人变更的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性 陈述或重大遗漏。 江苏天瑞仪器股份有限公司于近日收到全资子公司上海贝西生物科技有限 公司（以下简称"贝西生物"）通知，贝西生物于近日完成了法定代表人工商变 更登记手续，取得了上海市浦东新区市场监督管理局换发的《营业执照》。其法 定代表人由"刘佳丽"变更为"刘兵祥"。贝西生物变更后的新营业执照信息如 下： 公司名称：上海贝西生物科技有限公司 法定代表人：刘兵祥 成立日期：2005 年 07 月 18 日 注册资本：人民币 300.00 万元整 住所：上海市浦东新区广丹路 222 弄 20 号 经营范围：许可项目：第三类医疗器械经营；第二类医疗器械生产；第三类 医疗器械生产；货物进出口，技术进出口。（依法须经批准的项目，经相关部门 批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准） 一般项目：医疗器械、诊断试剂及相关设备的研发，并提供相关的技术开发、技 术咨询、技术服务、技术转让，化 ...

Core Viewpoint - ST Tianrui is undergoing a potential change in control, with its major shareholder and actual controller Liu Zhaogui planning to transfer control of the company, which may lead to a change in the company's controlling shareholder and actual controller [1] Group 1: Control Change Plans - Liu Zhaogui is currently planning a change in the company's control, with no agreements signed yet, and discussions ongoing regarding specific transaction plans [1] - The stock of ST Tianrui will be suspended from trading starting December 1, 2025, for a period not exceeding two trading days [1] - In May 2023, Liu Zhaogui had previously planned to transfer control of the company, signing a share transfer agreement with Guangzhou Liduo Virtual Reality Technology Partnership [1][2] Group 2: Share Issuance and Ownership Changes - The company signed a share subscription agreement with Guangzhou Liduo Technology Partnership, planning to issue up to 148,650,000 shares, raising a total of no more than 624.33 million yuan [2] - If the share transfer and issuance are completed, Liduo Virtual will hold 24,825,137 shares (3.85% of total shares post-issuance), and Liduo Technology will hold 148,650,000 shares (23.08% of total shares post-issuance), resulting in a change of control [2] Group 3: Financial Performance and Regulatory Issues - ST Tianrui has faced financial difficulties, reporting losses for four consecutive years since 2021, with a cumulative loss of 353 million yuan [3] - In the first three quarters of this year, the company reported revenue of 434.9 million yuan, a year-on-year decline of 26.15%, and a net profit loss of 1.218 million yuan, which is an improvement compared to the previous year [3] - Prior to the termination of the control change plan, the company was under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure [3]

Group 1 - Daqian Ecological announced the resignation of Chairman Zhang Yuan due to personal reasons, affecting his roles in the board and strategic committee [1] - Daqian Ecological, established in October 1988, focuses on urban renewal, rural revitalization, and ecological restoration [1] Group 2 - Haili Biological plans to use up to 500 million yuan of idle funds to invest in financial products issued by banks, brokers, trusts, and fund companies [1] - Haili Biological, founded in July 1981, specializes in in vitro diagnostic reagents and oral tissue repair and regeneration materials [1] Group 3 - Xianglou New Materials' application for a private placement of shares has been accepted by the Shenzhen Stock Exchange [2] - Xianglou New Materials, established in December 2005, is engaged in the research, production, and sales of customized precision stamping new materials [3] Group 4 - Zhuochuang Information has submitted an application for H-share listing to the Hong Kong Stock Exchange [4] - Zhuochuang Information, founded in April 2004, provides market data monitoring, trading price evaluation, industry data analysis, and research [4] Group 5 - Zhongwei Company plans to reduce its shareholding by up to 626,150 shares, representing 1% of the total share capital [5] - Zhongwei Company, established in May 2004, focuses on the research, production, and sales of high-end semiconductor equipment and related products [5] Group 6 - Jiarong Technology intends to raise up to 1 billion yuan through a private placement to acquire 100% of Hangzhou Lanran [6] - Jiarong Technology, founded in February 2005, specializes in membrane separation equipment and high-performance membrane components [6] Group 7 - Dameng Data's director and general manager Pi Yu has had his detention lifted by the local supervisory committee [7] - Dameng Data, established in November 2000, provides various database software, cloud computing, big data products, and related technical services [7] Group 8 - Huayang Co. has launched a 200-ton annual production project for high-performance carbon fiber [8] - Huayang Co., founded in December 1999, is involved in coal production, power generation, and renewable energy technologies [8] Group 9 - Saintno Biological's executives plan to collectively reduce their holdings by up to 37,600 shares, which is 0.024% of the total share capital [9] - Saintno Biological, established in July 2001, focuses on the research, production, and sales of peptide raw materials and formulations [9] Group 10 - *ST Dongyi is in the process of signing a comprehensive technical service agreement worth 635 million yuan [10] - *ST Dongyi, founded in November 1996, provides comprehensive home decoration services [11] Group 11 - Jiangxi Copper is attempting to acquire all shares of London-listed SolGold, with a recent offer of 26 pence per share [12] - Jiangxi Copper, established in January 1997, specializes in copper and gold mining, smelting, and processing [12] Group 12 - China Shenhua's subsidiary has successfully completed a 168-hour trial run of its power generation unit [13] - China Shenhua, founded in November 2004, is involved in coal and electricity production and sales [13] Group 13 - Baile Tianheng's subsidiary has received a milestone payment of 250 million USD from BMS [14] - Baile Tianheng, established in August 2006, focuses on innovative biopharmaceuticals and chemical preparations [14] Group 14 - Yulide's directors plan to reduce their holdings by up to 35,000 shares, representing 0.0313% of the total share capital [15] - Yulide, founded in December 2003, specializes in the research, production, and sales of testing and measuring instruments [15] Group 15 - Aters plans to establish joint ventures with its controlling shareholder to adjust its U.S. market operations [15] - Aters, established in April 2006, focuses on lithium-ion battery separator products and sterile packaging [15] Group 16 - Enjie Co. is planning to acquire 100% of Zhongke Hualian's shares, leading to a stock suspension [16] - Enjie Co., founded in April 2006, specializes in lithium-ion battery separator products and sterile packaging [16] Group 17 - ST Tianrui's controlling shareholder is planning a change in company control, resulting in a stock suspension [16] - ST Tianrui, established in July 2006, focuses on analytical testing instruments and environmental governance [17]

Core Viewpoint - ST Tianrui (SZ300165) is planning a change in control, which may lead to a shift in its major shareholder and actual controller, Liu Zhaogui, who currently holds 20.37% of the company's shares [2][3][6]. Group 1: Control Change Announcement - Liu Zhaogui, the founder and actual controller of ST Tianrui, is in the process of planning a change in the company's control, with the stock being suspended from trading starting December 1, 2023, for no more than two trading days [2]. - The transaction related to the control change is still uncertain, as no agreements have been signed, and discussions regarding the specific transaction plan are ongoing [3]. Group 2: Regulatory Issues and Penalties - ST Tianrui has been under risk warning since December 2024 due to violations related to revenue recognition, leading to a warning and fines totaling 3 million yuan for the company and additional fines for Liu Zhaogui and other executives [3][7]. - The previous attempt to change control was halted due to an investigation by the China Securities Regulatory Commission (CSRC) [4]. Group 3: Financial Performance - ST Tianrui's financial performance has been declining, with revenue dropping to 851 million yuan in 2024, only 55.2% of its 2021 revenue, and a cumulative net loss of 354 million yuan since 2021 [7]. - The company specializes in analytical testing instruments and environmental governance, with core products including spectrometers and chromatographs [7].